ESOPMay 1, 2026, 04:07 PM
Candel Therapeutics Grants 29,400 Stock Options to New Employees
AI Summary
Candel Therapeutics, Inc. announced that its Compensation Committee granted stock options for an aggregate of 29,400 shares of common stock to two new employees on April 30, 2026. The options, with an exercise price of $6.18 per share, were issued under the Company's 2025 Inducement Plan. These awards are intended to incentivize the new employees and will vest over four years, with 25% vesting on the first anniversary and the remainder in monthly installments.
Key Highlights
- Candel Therapeutics granted stock options for 29,400 shares of common stock.
- Options were issued to two new employees.
- The per share exercise price for the options is $6.18.
- Awards were made under the Company's 2025 Inducement Plan.
- Vesting schedule: 25% on the first anniversary, then 36 equal monthly installments.
- The grants serve as inducement for employment, per Nasdaq Listing Rule 5635(c)(4).
Price Impact
More from CADL